Le Lézard
Classified in: Health
Subjects: PSF, CFG

Public advisory - Unauthorized prescription and controlled drugs seized from two natural food stores in Sudbury, Ontario, because they may pose serious health risks


OTTAWA, ON, Feb. 20, 2023 /CNW/ - 

Summary

Images

PNF-Vitamin-D3-4000-IU (CNW Group/Health Canada)

Natrix-Dioscorene-Progesterone-Cream (CNW Group/Health Canada)

Paragon-Amore-Exotic-Herbal-Formula (CNW Group/Health Canada)

PNF-Vitamin-D3-4000-IU (CNW Group/Health Canada)

PNF-Vitamin-D3-10000-IU (CNW Group/Health Canada)

Affected products

Product

Promoted use

Prescription drug on the label

Retailer

DHEA (Dehydroepiandrosterone)

 

Workout supplement

Labelled to contain DHEA (dehydroepiandrosterone)

Paris Natural Foods

1500 Paris Street

Sudbury, ON

 

Natrix Nutraceuticals Inc.

Dioscorene Natural Progesterone Cream

 

Hormone replacement therapy

Labelled to contain progesterone

Paris Natural Foods

1500 Paris Street

Sudbury, ON

Paragon Alternative Medical Clinic

Amore Exotic Herbal Formula

Sexual enhancement

Labelled to contain yohimbe

Paris Natural Foods

1500 Paris Street

Sudbury, ON

Paris Natural Foods Vitamin D3 (4,000 IU)

 

Vitamin supplement

Labelled to contain prescription-strength vitamin D3

Paris Natural Foods

1500 Paris Street

Sudbury, ON

 

Durham Natural Foods

1191 Montrose Avenue Sudbury, ON

Paris Natural Foods Vitamin D3 (10,000 IU)

Vitamin supplement

Labelled to contain prescription-strength vitamin D3

Paris Natural Foods

1500 Paris Street

Sudbury, ON

 

Durham Natural Foods

1191 Montrose Avenue Sudbury, ON

Issue

Health Canada seized unauthorized health products from two natural food stores in Sudbury, Ontario, because the products are labelled to contain prescription or controlled drugs, which may pose serious health risks.

The unauthorized products include prescription-strength vitamin D3 supplements, hormones in capsule and cream format, and a sexual enhancement product.

Selling unauthorized health products in Canada is illegal. Unauthorized health products have not been approved by Health Canada, which means that they have not been assessed for safety, efficacy and quality and may pose a range of serious health risks. For example, they could contain high-risk ingredients, such as prescription drugs, additives or contaminants that may or may not be listed on the label. These ingredients could interact with other medications and foods. In addition, these products may not actually contain the active ingredients that consumers would expect them to contain to help maintain and improve their health.

Prescription drugs should only be used under the advice and supervision of a health care professional because they are used to treat specific conditions and may cause serious side effects. Prescription drugs can only be legally sold with a prescription.

 What you should do

Background

Dehydroepiandrosterone (DHEA) is a controlled substance that can cause higher-than-normal levels of female and male hormones in the body and could increase the risk of prostate, breast, ovarian and other hormone-sensitive cancers. Potential side effects include serious cardiovascular disease, and changes in fertility and sperm production. DHEA should be avoided by individuals with a history of abnormal heart rhythms, blood clotting disorders, liver disease and those who are pregnant or breastfeeding.

Progesterone is a prescription drug and can be associated with serious side effects, particularly in patients at risk of blood clots. Patients who are taking progesterone-containing medications (such as birth control pills or hormone replacement therapy) may be at an increased risk due to their overall progesterone exposure. Health risks from the use of a progesterone cream would likely arise with long term use.

Vitamin D is considered a prescription drug when taken orally (by mouth) at doses of more than 2,500 International Units (IU) per day. Too much vitamin D can lead to vitamin D "intoxication," which can cause weakness, fatigue, drowsiness, headache, lack of appetite, dry mouth, metallic taste, nausea, vomiting, vertigo, ringing in the ears, lack of coordination, and muscle weakness. Pregnant people in particular should not take vitamin D exceeding the daily tolerable upper intake level for adults (4,000 IU). High levels of vitamin D taken during pregnancy can potentially lead to high calcium levels in the pregnant person, which can be associated with risks to the newborn.

Yohimbine is a prescription drug and should be used only under the supervision of a health care professional. Yohimbine is derived from yohimbe, a bark extract. The use of yohimbine or yohimbe may result in serious adverse reactions, particularly in people with high blood pressure or heart, kidney or liver disease. Side effects include increased blood pressure and heart rate, anxiety, dizziness, tremors, headache, nausea and sleep disorders. It should not be used by people who are pregnant or breastfeeding.

Également disponible en français

SOURCE Health Canada


These press releases may also interest you

at 13:26
In a bid to foster excellence and innovation in the healthcare industry, the esteemed Dr. Vidal Sheen proudly announces the launch of The Dr. Vidal Sheen Grant for Healthcare Students. With a robust focus on academic prowess, compassionate care, and...

at 13:17
Rexall is proud to unveil its first Pharmacist Care Walk-In Clinic in Barrie, Ontario on Friday, April 19. Located at 353 Duckworth Street, the clinic will offer personalized care to the community while providing immediate pharmacist treatment for...

at 13:13
Caring for communities extends beyond life-changing work in operating rooms and physician offices. Hartford HealthCare leadership today highlighted its corporate responsibility to environmental, social and economic sustainability in announcing its...

at 13:04
Concept Medical, a pioneer in innovative drug delivery technologies, proudly announces the commencement of its groundbreaking IDE clinical study, "MAGICAL-ISR" using MagicTouch ? Sirolimus drug coated balloon (DCB), for the management of in-stent...

at 12:30
The American College of Physicians (ACP) today released an update of its 2017 guideline with clinical recommendations for the use of newer pharmacological treatments of adults with Type 2 diabetes. The clinical guideline is based on the best...

at 12:10
Pieris Pharmaceuticals, Inc. today announced that its Board of Directors has approved a 1-for-80 reverse stock split of the Company's common stock, par value $0.001, which will be effective at 5:00 pm Eastern Time on April 22, 2024. The Company's...



News published on and distributed by: